Molecular epidemiologic features of inflammatory breast cancer: A comparison between Egyptian and US patients

An Chi Lo, Celina G. Kleer, Mousumi Banerjee, Sherif Omar, Hussein Khaled, Saad Eissa, Ahmed Hablas, Julie A. Douglas, Sharon H. Alford, Sofia D. Merajver, Amr S. Soliman

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

Background: Inflammatory breast cancer (IBC) is a lethal form of breast cancer with unknown etiology. A higher frequency of IBC and a more aggressive IBC phenotype was reported in Egypt than in the United States. This difference in disease frequency and presentation might be related to molecular epidemiologic factors. Methods: We used tumor blocks and demographic, epidemiologic, and clinical data of 48 IBC patients from Egypt and 12 patients from the United States. We counted tumor emboli in tumors before and after immunohistochemical staining with lymphatic vessel endothelial receptor-1 (LYVE-1), and measured the expression of RhoC GTPase protein in the two groups. Results: Erythema, edema, and peau d'orange were found in 77% of the Egyptian patients as compared with 29% found in the US patients (P = 0.02). The number of tumor emboli was significantly higher in tumors from Egypt (mean ± SD, 14.1 ± 14.0) than in the tumors from the United States (5.0 ± 4.0, P = 0.01). The number of tumor emboli in LYVE-1 positive vessels was higher in tumors from Egypt (3.5 ± 2.8) than tumors from the United States (1.6 ± 0.5, P = 0.15). We detected a high level of RhoC in 87% of the tumors from Egypt and 14% of the tumors from the United States (P = 0.0003). Conclusion: Patients from Egypt have a more aggressive form of IBC than those in the United States. Our analysis of IBC patients shows that distinct molecular phenotypes can be found when these two study populations are compared. Future studies should explore the epidemiologic and environmental exposures and the genetic factors that might lead to the different clinical and molecular features of IBC in patients from these two countries.

Original languageEnglish (US)
Pages (from-to)141-147
Number of pages7
JournalBreast Cancer Research and Treatment
Volume112
Issue number1
DOIs
StatePublished - Nov 2008

Keywords

  • Inflammatory breast cancer
  • International
  • LYVE-1
  • Molecular epidemiology
  • RhoC
  • Tumor emboli

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Molecular epidemiologic features of inflammatory breast cancer: A comparison between Egyptian and US patients'. Together they form a unique fingerprint.

  • Cite this

    Lo, A. C., Kleer, C. G., Banerjee, M., Omar, S., Khaled, H., Eissa, S., Hablas, A., Douglas, J. A., Alford, S. H., Merajver, S. D., & Soliman, A. S. (2008). Molecular epidemiologic features of inflammatory breast cancer: A comparison between Egyptian and US patients. Breast Cancer Research and Treatment, 112(1), 141-147. https://doi.org/10.1007/s10549-007-9833-z